Skip to main content
. 2020 May 15;11:245. doi: 10.3389/fpsyt.2020.00245

Table 1.

Diagnostic findings, initially (2009/10) and at follow-up (2019).

Investigation Initial findings (2009/2010; [9]) Follow-up findings (2019)
Basic blood analyses
  • Glutamate pyruvate transaminase (GPT) was elevated (70 U/l; reference 10–35 U/l), γ-glutamyl transferase (γ-GT) was elevated (72 U/l; reference 0–40 U/l), other liver values were normal.

  • Thyroid-stimulating hormone was elevated (4.77 µU/ml; reference 0.27–4.20 µU/ml), triiodothyronine, and thyroxine levels were in normal range.

  • Normal liver values.

  • Thyroid-stimulating hormone, triiodothyronine, and thyroxine levels were in normal ranges.

  • Vitamin B12/D, folic acid and selenium were normal.

Antibody findings
  • Screening for antibodies against neuronal cell surface antigens showed IgG antibodies against the NMDA-R (NR1-subunit; in the reference laboratory in Oxford using a live cell-based assay). Antibody against SOX1 were non-specifically slightly positive.

  • Autoantibodies against TSH-receptor (TRAK) were elevated (4.77 µU/ml; reference 0.27–4.20 µU/ml), autoantibodies against thyroglobulin and thyroid peroxidase were normal.

  • No screening for other immunological/rheumatological alterations was conducted.

  • Antibodies against different neuronal cell surface antigens (AMPA-R, DPPX, GABA-B-R, LGI1, Caspr2, and NMDA-R) were negative in serum (using biochip-assays from Euroimmun®).

  • No antibodies against the intracellular onconeural antigens Yo, Hu, CV2/CRMP5, Ri, Ma1/2, SOX1, Tr(DNER), Zic4, or the intracellular synaptic antigens GAD65/amphiphysin were found (using Ravo line assay®).

  • Autoantibodies against thyroglobulin, TSH receptor and thyroid peroxidase were not increased.

  • Screening for antinuclear antibodies (ANA) showed a slightly positive homogenously result against nucleus and chromosomes (HEp-2), AMA/LKM, and anti-DFS70 were borderline positive (+).

  • Anti-neutrophil cytoplasmic antibodies, antiphospholipid antibodies, rheumatoid factor, and anti-mitochondrial antibodies were negative. CH50 was slightly increased (131, reference: 65-115%), no other changes in the complement system (C3, C4, CH50, C3d) were observed.

  • Normal serum IgA, IgM und IgG immunoglobulin concentrations; immunofixation showed no monoclonal antibody production.

  • Anti AQP4-IgG and MOG-IgG antibodies were negative.

Cerebrospinal fluid analyses
  • Initially slight pleocytosis (23 µl; reference <5/µl). In the course normal white blood cell count (1/µl; reference <5/µl).

  • Slightly elevated protein concentration (561 mg/L; reference <450 mg/L), and elevated age-corrected albumin quotient: 8.7; age-dependent reference <6.5 × 10−3)


No CSF-specific oligoclonal bands;
IgG index not increased
(0.53; reference ≤0.7).
  • No lumbar puncture was conducted.

Cerebral magnetic resonance imaging with combined volume- and region-based analysis method (CVR) analysis
  • Inconspicuous findings, especially for the hippocampal regions and in the structures of the limbic system.

  • Enlargement of the lateral ventricles with emphasis on the posterior horns and slight striatal and insular atrophy.

  • Except for a few non-specific right-frontal white matter lesions, the findings were essentially unchanged.

Electroencephalography – visual assessment
  • Intermittent delta focus over the right central areas.

  • Occipital α-activity (11 Hz).

Independent component analyses
  • 1) Right and left frontotemporal delta waves; 2) a deep right temporal generator; and 3) a central component with theta frequencies.

  • Left-side spike-wave activity and intermittent rhythmic delta activity.

[18F]fluorodeoxyglucose positron emission tomography
  • Global cortical hypometabolism of the left hemisphere and right-temporal accentuation was detected.

  • Cerebellar hypometabolism predominantly on the right side (most likely indicating crossed cerebellar diaschisis).

  • Not performed.

Cardiovascular examinations
  • Inconspicuous resting electrocardiography.

  • Inconspicuous transthoracic echocardiography.

  • Inconspicuous resting electrocardiography.

  • Raised long-term blood pressure.

Neuropsychological testing
  • Slower reaction times with evidence for heightened irritability and severely impaired ability to increase attention.

  • Considerable amount of missings and errors in divided attention task.

  • Severe deficits in cognitive flexibility.

  • Considerable amount of missings and errors in working memory task

  • Slower reaction times with retained ability to increase attention.

  • Considerable amount of missings and mean level of errors in divided attention task.

  • Moderate deficits in cognitive flexibility.

  • Considerable amount of missings and mean level of errors in working memory task